false 2020 Q3 0001272842 --12-31 2020 P12M P12M P12M P12M P5Y P10Y P9Y P3Y P10Y P9Y P3Y P7Y9M18D P6Y10M24D P7Y9M18D 0001272842 2020-01-01 2020-09-30 xbrli:shares 0001272842 2020-11-02 iso4217:USD 0001272842 2020-09-30 0001272842 2019-12-31 iso4217:USD xbrli:shares 0001272842 2020-07-01 2020-09-30 0001272842 2019-07-01 2019-09-30 0001272842 2019-01-01 2019-09-30 0001272842 2020-06-30 0001272842 2019-06-30 0001272842 2018-12-31 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2020-06-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2019-06-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2019-12-31 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2018-12-31 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2020-09-30 0001272842 airg:CommonStockAndAdditionalPaidInCapitalMember 2019-09-30 0001272842 us-gaap:TreasuryStockMember 2020-06-30 0001272842 us-gaap:TreasuryStockMember 2019-06-30 0001272842 us-gaap:TreasuryStockMember 2019-12-31 0001272842 us-gaap:TreasuryStockMember 2018-12-31 0001272842 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001272842 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0001272842 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0001272842 us-gaap:TreasuryStockMember 2020-09-30 0001272842 us-gaap:TreasuryStockMember 2019-09-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001272842 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001272842 us-gaap:RetainedEarningsMember 2020-06-30 0001272842 us-gaap:RetainedEarningsMember 2019-06-30 0001272842 us-gaap:RetainedEarningsMember 2019-12-31 0001272842 us-gaap:RetainedEarningsMember 2018-12-31 0001272842 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001272842 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001272842 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001272842 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001272842 us-gaap:RetainedEarningsMember 2020-09-30 0001272842 us-gaap:RetainedEarningsMember 2019-09-30 0001272842 2019-09-30 airg:Segment 0001272842 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001272842 us-gaap:StockOptionMember 2019-01-01 2019-09-30 0001272842 airg:StockOptionsAndRestrictedStockMember 2020-07-01 2020-09-30 0001272842 airg:StockOptionsAndRestrictedStockMember 2019-07-01 2019-09-30 0001272842 airg:StockOptionsAndRestrictedStockMember 2020-01-01 2020-09-30 0001272842 airg:StockOptionsAndRestrictedStockMember 2019-01-01 2019-09-30 0001272842 us-gaap:WarrantMember 2020-07-01 2020-09-30 0001272842 us-gaap:WarrantMember 2019-07-01 2019-09-30 0001272842 us-gaap:WarrantMember 2020-01-01 2020-09-30 0001272842 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001272842 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2020-09-30 0001272842 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2020-09-30 0001272842 us-gaap:FairValueInputsLevel2Member 2020-09-30 0001272842 us-gaap:FairValueInputsLevel1Member 2020-09-30 0001272842 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001272842 us-gaap:RepurchaseAgreementsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001272842 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2019-12-31 0001272842 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-12-31 0001272842 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001272842 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001272842 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001272842 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001272842 us-gaap:PropertyPlantAndEquipmentOtherTypesMember srt:MinimumMember 2020-01-01 2020-09-30 0001272842 us-gaap:PropertyPlantAndEquipmentOtherTypesMember srt:MaximumMember 2020-01-01 2020-09-30 0001272842 airg:ComputersAndSoftwareMember 2020-09-30 0001272842 airg:ComputersAndSoftwareMember 2019-12-31 0001272842 us-gaap:FurnitureAndFixturesMember 2020-09-30 0001272842 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001272842 us-gaap:MachineryAndEquipmentMember 2020-09-30 0001272842 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001272842 us-gaap:ConstructionInProgressMember 2020-09-30 0001272842 us-gaap:ConstructionInProgressMember 2019-12-31 0001272842 us-gaap:LeaseholdImprovementsMember 2020-09-30 0001272842 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001272842 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-09-30 0001272842 us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-09-30 0001272842 us-gaap:TradeNamesMember 2020-01-01 2020-09-30 0001272842 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0001272842 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-12-31 0001272842 us-gaap:TradeNamesMember 2019-01-01 2019-12-31 0001272842 us-gaap:CustomerRelationshipsMember 2020-09-30 0001272842 us-gaap:DevelopedTechnologyRightsMember 2020-09-30 0001272842 us-gaap:TradeNamesMember 2020-09-30 0001272842 us-gaap:CustomerRelationshipsMember 2019-12-31 0001272842 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001272842 us-gaap:TradeNamesMember 2019-12-31 0001272842 airg:SiliconValleyBankMember us-gaap:RevolvingCreditFacilityMember 2018-01-31 0001272842 airg:SiliconValleyBankMember us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001272842 airg:SiliconValleyBankMember us-gaap:RevolvingCreditFacilityMember 2018-01-01 2018-01-31 xbrli:pure 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramAugustTwoZeroOneSevenMember 2017-08-31 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramAugustTwoZeroOneSevenMember 2017-08-01 2017-08-31 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramAugustTwoZeroOneSevenMember 2018-08-06 2018-08-07 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramSeptemberNineTwoZeroOneNineMember 2019-09-09 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramSeptemberNineTwoZeroOneNineMember 2019-08-10 2019-09-09 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramSeptemberNineTwoZeroOneNineMember 2020-09-09 2020-09-09 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramAugustTwoZeroOneSevenAndSeptemberTwoZeroOneNineMember 2020-07-01 2020-09-30 0001272842 us-gaap:CommonStockMember airg:ShareRepurchaseProgramAugustTwoZeroOneSevenAndSeptemberTwoZeroOneNineMember 2020-01-01 2020-09-30 0001272842 airg:ShareRepurchaseProgramSeptemberNineTwoZeroOneNineMember 2019-09-10 2020-09-30 0001272842 airg:ShareRepurchaseProgramSeptemberNineTwoZeroOneNineMember 2020-09-30 0001272842 airg:WarrantsIssuedAndOutstandingMember 2020-09-30 0001272842 airg:WarrantsIssuedAndOutstandingMember 2019-12-31 0001272842 airg:StockOptionAwardsIssuedAndOutstandingMember 2020-09-30 0001272842 airg:StockOptionAwardsIssuedAndOutstandingMember 2019-12-31 0001272842 airg:TwoThousandAndSixteenEquityIncentivePlanMember 2020-09-30 0001272842 airg:TwoThousandAndSixteenEquityIncentivePlanMember 2019-12-31 0001272842 airg:TwoThousandAndSixteenEmployeeStockPurchasePlanMember 2020-09-30 0001272842 airg:TwoThousandAndSixteenEmployeeStockPurchasePlanMember 2019-12-31 0001272842 airg:TwoThousandAndSixteenEquityIncentivePlanMember 2020-01-01 2020-01-01 0001272842 airg:TwoThousandAndSixteenEmployeeStockPurchasePlanMember 2020-01-01 2020-01-01 0001272842 2019-01-01 2019-12-31 0001272842 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001272842 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001272842 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001272842 us-gaap:RestrictedStockUnitsRSUMember 2020-09-30 0001272842 us-gaap:EmployeeStockMember 2020-01-01 2020-09-30 0001272842 us-gaap:EmployeeStockMember srt:MaximumMember 2020-01-01 2020-09-30 0001272842 us-gaap:EmployeeStockMember 2020-09-30 0001272842 us-gaap:EmployeeStockMember 2020-02-01 2020-02-29 0001272842 us-gaap:EmployeeStockMember 2020-08-01 2020-08-31 0001272842 airg:OfficeSpaceAndResearchFacilitiesLeaseMember 2020-07-01 2020-09-30 0001272842 airg:OfficeSpaceAndResearchFacilitiesLeaseMember 2019-07-01 2019-09-30 0001272842 airg:OfficeSpaceAndResearchFacilitiesLeaseMember 2020-01-01 2020-09-30 0001272842 airg:OfficeSpaceAndResearchFacilitiesLeaseMember 2019-01-01 2019-09-30 0001272842 airg:OfficeSpaceAndResearchFacilitiesLeaseMember 2020-09-30 0001272842 airg:SupplyAgreementMember srt:MaximumMember 2020-09-01 2020-09-30 0001272842 airg:SupplyAgreementMember 2020-09-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerDMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerDMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerDMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:SalesRevenueNetMember airg:CustomerDMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerDMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001272842 us-gaap:AccountsReceivableMember airg:CustomerDMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 airg:Vendor 0001272842 country:CN 2020-07-01 2020-09-30 0001272842 country:CN 2020-01-01 2020-09-30 0001272842 airg:SalesChannelFulfillmentDistributorsMember 2020-07-01 2020-09-30 0001272842 airg:SalesChannelFulfillmentDistributorsMember 2019-07-01 2019-09-30 0001272842 airg:SalesChannelFulfillmentDistributorsMember 2020-01-01 2020-09-30 0001272842 airg:SalesChannelFulfillmentDistributorsMember 2019-01-01 2019-09-30 0001272842 airg:SalesChannelOEMODMContractManufacturerMember 2020-07-01 2020-09-30 0001272842 airg:SalesChannelOEMODMContractManufacturerMember 2019-07-01 2019-09-30 0001272842 airg:SalesChannelOEMODMContractManufacturerMember 2020-01-01 2020-09-30 0001272842 airg:SalesChannelOEMODMContractManufacturerMember 2019-01-01 2019-09-30 0001272842 airg:SalesChannelOtherMember 2020-07-01 2020-09-30 0001272842 airg:SalesChannelOtherMember 2019-07-01 2019-09-30 0001272842 airg:SalesChannelOtherMember 2020-01-01 2020-09-30 0001272842 airg:SalesChannelOtherMember 2019-01-01 2019-09-30 0001272842 country:CN 2019-07-01 2019-09-30 0001272842 country:CN 2019-01-01 2019-09-30 0001272842 srt:NorthAmericaMember 2020-07-01 2020-09-30 0001272842 srt:NorthAmericaMember 2019-07-01 2019-09-30 0001272842 srt:NorthAmericaMember 2020-01-01 2020-09-30 0001272842 srt:NorthAmericaMember 2019-01-01 2019-09-30 0001272842 airg:RestOfWorldMember 2020-07-01 2020-09-30 0001272842 airg:RestOfWorldMember 2019-07-01 2019-09-30 0001272842 airg:RestOfWorldMember 2020-01-01 2020-09-30 0001272842 airg:RestOfWorldMember 2019-01-01 2019-09-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM       TO       

Commission file number: 001-37851

 

AIRGAIN, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

95-4523882

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification No.)

 

 

 

3611 Valley Centre Drive, Suite 150

San Diego, CA

 

92130

(Address of Principal Executive Offices)

 

(Zip Code)

(760) 579-0200

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common shares, par value $0.0001 per share

AIRG

Nasdaq

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes    No

 

As of November 2, 2020, the registrant had 9,767,957 shares of Common Stock (par value $0.0001) outstanding.

 


 

AIRGAIN, INC.

Form 10-Q

For the Quarter Ended September 30, 2020

 

 

 

 

 

Page

PART I. FINANCIAL INFORMATION

 

Item 1. Condensed Financial Statements (Unaudited)

 

Condensed Balance Sheets

3

Condensed Statements of Operations

4

Condensed Statements of Comprehensive Income (Loss)

5

Condensed Statements of Stockholders’ Equity

6

Condensed Statements of Cash Flows

7

Notes to Condensed Financial Statements

8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

Item 3. Quantitative and Qualitative Disclosures about Market Risk

24

Item 4. Controls and Procedures

24

 

 

 

 

PART II. OTHER INFORMATION

Item 1.Legal Proceedings

24

Item 1A. Risk Factors

24

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

25

Item 3. Defaults Upon Senior Securities

25

Item 4. Mine Safety Disclosures

25

Item 5. Other Information

25

Item 6. Exhibits

25

 

 

SIGNATURES

26

 

 

 

 


 

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Airgain, Inc.

Condensed Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

September 30, 2020

 

 

December 31, 2019

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

35,795

 

 

$

13,197

 

Short-term investments

 

 

2,184

 

 

 

21,686

 

Trade accounts receivable

 

 

4,182

 

 

 

7,656

 

Inventory

 

 

1,077

 

 

 

1,193

 

Prepaid expenses and other current assets

 

 

1,469

 

 

 

1,361

 

Total current assets

 

 

44,707

 

 

 

45,093

 

Property and equipment, net

 

 

2,323

 

 

 

2,126

 

Goodwill

 

 

3,700

 

 

 

3,700

 

Customer relationships, net

 

 

2,748

 

 

 

3,110

 

Intangible assets, net

 

 

574

 

 

 

687

 

Other assets

 

 

197

 

 

 

10

 

Total assets

 

$

54,249

 

 

$

54,726

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

3,078

 

 

$

3,838

 

Accrued bonus

 

 

1,220

 

 

 

1,385

 

Accrued liabilities and other

 

 

1,653

 

 

 

1,536

 

Total current liabilities

 

 

5,951

 

 

 

6,759

 

Deferred tax liability

 

 

44

 

 

 

52

 

Deferred rent obligation under operating lease

 

 

190

 

 

 

11

 

Total liabilities

 

 

6,185

 

 

 

6,822

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock and additional paid-in capital, par value $0.0001, 200,000 shares authorized; 10,302 shares issued and 9,768 shares outstanding at September 30, 2020; and 10,146 shares issued and 9,681 shares outstanding at December 31, 2019

 

 

99,597

 

 

 

96,623

 

Treasury stock, at cost: 534 shares and 465 shares at September 30, 2020, and December 31, 2019, respectively

 

 

(5,267

)

 

 

(4,659

)

Accumulated other comprehensive income

 

 

1

 

 

 

8

 

Accumulated deficit

 

 

(46,267

)

 

 

(44,068

)

Total stockholders’ equity

 

 

48,064

 

 

 

47,904

 

Commitments and contingencies (note 12)

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

54,249

 

 

$

54,726

 

 

 

See accompanying notes.

3


 

Airgain, Inc.

Condensed Statements of Operations

(In thousands, except per share data)

(Unaudited)

 

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Sales

$

13,010

 

 

$

13,142

 

 

$

35,672

 

 

$

42,713

 

Cost of goods sold

 

6,981

 

 

 

7,067

 

 

 

18,924

 

 

 

23,167

 

Gross profit

 

6,029

 

 

 

6,075

 

 

 

16,748

 

 

 

19,546

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

2,231

 

 

 

2,403

 

 

 

6,873

 

 

 

6,944

 

Sales and marketing

 

1,559

 

 

 

1,461

 

 

 

4,477

 

 

 

5,964

 

General and administrative

 

2,439

 

 

 

2,416

 

 

 

7,506

 

 

 

6,168

 

Total operating expenses

 

6,229

 

 

 

6,280

 

 

 

18,856

 

 

 

19,076

 

Income (loss) from operations

 

(200

)

 

 

(205

)

 

 

(2,108

)

 

 

470

 

Other expense (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income, net

 

(23

)

 

 

(183

)

 

 

(194

)

 

 

(558

)

Other expense

 

 

 

 

 

 

 

11

 

 

 

 

Total other income

 

(23

)

 

 

(183

)

 

 

(183

)

 

 

(558

)

Income (loss) before income taxes

 

(177

)

 

 

(22

)

 

 

(1,925

)

 

 

1,028

 

Provision for income taxes

 

84

 

 

 

113

 

 

 

274

 

 

 

165

 

Net income (loss)

$

(261

)

 

$

(135

)

 

$

(2,199

)

 

$

863

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

(0.03

)

 

$

(0.01

)

 

$

(0.23

)

 

$

0.09

 

Diluted

$

(0.03

)

 

$

(0.01

)

 

$

(0.23

)

 

$

0.09

 

Weighted average shares used in calculating income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

9,710

 

 

 

9,711

 

 

 

9,694

 

 

 

9,678

 

Diluted

 

9,710

 

 

 

9,711

 

 

 

9,694

 

 

 

10,083

 

 

 

See accompanying notes.

4


 

Airgain, Inc.

Condensed Statements of Comprehensive Income (Loss)

(In thousands)

(Unaudited)

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

Net income (loss)

 

$

(261

)

 

$

(135

)

 

$

(2,199

)

 

$

863

 

 

Unrealized gain (loss) on available-for-sale securities, net of deferred taxes

 

 

(15

)

 

 

1

 

 

 

(7

)

 

 

24

 

 

Comprehensive income (loss)

 

$

(276

)

 

$

(134

)

 

$

(2,206

)

 

$

887

 

 

 

 

See accompanying notes.

5


 

Airgain, Inc.

Condensed Statements of Stockholders’ Equity

(In thousands)

(Unaudited)

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Total stockholders' equity, beginning balance

 

$

46,779

 

 

$

47,620

 

 

$

47,904

 

 

$

45,147

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock and additional paid-in capital:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Balance at beginning of period

 

 

98,036

 

 

 

95,229

 

 

 

96,623

 

 

 

93,584

 

    Stock-based compensation

 

 

633

 

 

 

549

 

 

 

1,956

 

 

 

1,605

 

    Issuance of shares for stock purchase plan

 

 

928

 

 

 

190

 

 

 

1,018

 

 

 

779

 

  Balance at end of period

 

 

99,597

 

 

 

95,968

 

 

 

99,597

 

 

 

95,968

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Treasury stock:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Balance at beginning of period

 

 

(5,267

)

 

 

(3,625

)

 

 

(4,659

)

 

 

(3,432

)

    Repurchases of common stock

 

 

 

 

 

(606

)

 

 

(608

)

 

 

(799

)

  Balance at end of period

 

 

(5,267

)

 

 

(4,231

)

 

 

(5,267

)

 

 

(4,231

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Balance at beginning of period

 

 

16

 

 

 

12

 

 

 

8

 

 

 

(11

)

    Other comprehensive income (loss)

 

 

(15

)

 

 

1

 

 

 

(7

)

 

 

24

 

  Balance at end of period

 

 

1

 

 

 

13

 

 

 

1

 

 

 

13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated deficit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Balance at beginning of period

 

 

(46,006

)

 

 

(43,996

)

 

 

(44,068

)

 

 

(44,994

)

    Net income (loss)

 

 

(261

)

 

 

(135

)

 

 

(2,199

)

 

 

863

 

  Balance at end of period

 

 

(46,267

)

 

 

(44,131

)

 

 

(46,267

)

 

 

(44,131

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stockholders' equity, ending balance

 

$

48,064

 

 

$

47,619

 

 

$

48,064

 

 

$

47,619

 

 

See accompanying notes.

6


 

Airgain, Inc.

Condensed Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(2,199

)

 

$

863

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

 

348

 

 

 

373

 

Loss on disposal of property and equipment

 

 

11

 

 

 

 

Amortization

 

 

475

 

 

 

491

 

Amortization of premium (discounts) on investments, net

 

 

49

 

 

 

(248

)

Stock-based compensation

 

 

1,956

 

 

 

1,605

 

Deferred tax liability

 

 

(8

)

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

3,474

 

 

 

(1,551

)

Inventory

 

 

116

 

 

 

86

 

Prepaid expenses and other assets

 

 

(120

)

 

 

(500

)

Accounts payable

 

 

(756

)

 

 

305

 

Accrued bonus

 

 

(165

)

 

 

(674

)

Accrued liabilities and other

 

 

296

 

 

 

125

 

Net cash provided by operating activities

 

 

3,477

 

 

 

875

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of available-for-sale securities

 

 

(753

)

 

 

(30,080

)

Maturities of available-for-sale securities

 

 

20,199

 

 

 

29,520

 

Purchases of property and equipment

 

 

(560

)

 

 

(1,045

)

Net cash provided by (used in) investing activities

 

 

18,886

 

 

 

(1,605

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Repurchases of common stock

 

 

(608

)

 

 

(799

)

Proceeds from issuance of common stock, net

 

 

1,018

 

 

 

779

 

Net cash provided by (used in) financing activities

 

 

410

 

 

 

(20

)

Net increase (decrease) in cash, cash equivalents and restricted cash

 

 

22,773

 

 

 

(750

)

Cash, cash equivalents, and restricted cash; beginning of period

 

 

13,197

 

 

 

13,621

 

Cash, cash equivalents, and restricted cash; end of period

 

$

35,970

 

 

$

12,871

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Taxes paid

 

$

137

 

 

$

54

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Accrual of property and equipment

 

$

 

 

$

4

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

35,795

 

 

$

12,871

 

Restricted cash included in other assets

 

 

175

 

 

 

 

Total cash, cash equivalents, and restricted cash

 

$

35,970

 

 

$

12,871

 

 

 

See accompanying notes.

7


 

Airgain, Inc.

Notes to Condensed Financial Statements

(Unaudited)

 

Note 1. Description of Business and Basis of Presentation

 

Business Description

 

Airgain, Inc. (the Company) was incorporated in the State of California on March 20, 1995; and reincorporated in the State of Delaware on August 15, 2016. The Company is a leading provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of markets, including consumer, enterprise and automotive. The Company designs, develops, and engineers its antenna products for original equipment and design manufacturers worldwide. The Company’s headquarters is in San Diego, California with office space and research, design and test facilities in the United States, United Kingdom, China, and Taiwan.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Interim financial results are not necessarily indicative of results anticipated for the full year. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, from which the balance sheet information herein was derived.

 

The unaudited condensed balance sheet as of December 31, 2019, included herein was derived from the audited financial statements as of that date but does not include all disclosures including notes required by GAAP.

 

The unaudited condensed statements of operations for the three and nine months ended September 30, 2020 and 2019, and the balance sheet data as of September 30, 2020, have been prepared on the same basis as the audited financial statements.

 

In the opinion of management, the accompanying unaudited condensed financial statements reflect all adjustments, consisting of normal and recurring adjustments, necessary for a fair presentation of results of the Company’s operations and financial position for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2020, or for any future period.

 

Segment Information

 

The Company’s operations are located primarily in the United States and most of its assets are located in San Diego, California and Scottsdale, Arizona. The Company operates in one segment related to the sale of antenna products. The Company’s chief operating decision-maker is its chief executive officer, who reviews operating results on an aggregate basis and manages the Company’s operations as a single operating segment.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Reclassifications

 

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements.

 

Fair Value Measurements

 

The carrying values of the Company’s financial instruments, including cash and cash equivalents, restricted cash, trade accounts receivable, accounts payable, and accrued liabilities approximate their fair values due to the short maturity of these instruments.

8


Airgain, Inc.

Notes to Condensed Financial Statements

(Unaudited)

 

Fair value measurements are market-based measurements, not entity-specific measurements. Therefore, fair value measurements are determined based on the assumptions that market participants would use in pricing the asset or liability. The Company follows a three-level hierarchy to prioritize the inputs used in the valuation techniques to derive fair values. The basis for fair value measurements for each level within the hierarchy is described below:

Level 1: Quoted prices in active markets for identical assets or liabilities.

Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.

Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable in active markets.

 

Cash Equivalents and Short-Term Investments

 

Cash equivalents are comprised of short-term, highly liquid investments with maturities of 90 days or less at the date of purchase. Short-term investments consist predominantly of commercial paper, corporate debt securities, U.S. Treasury securities and asset backed securities. The Company classifies short-term investments based on the facts and circumstances surrounding the investments at the time of purchase and evaluates such classification as of each balance sheet date. All short-term investments are classified as available-for-sale securities as of September 30, 2020, and are recorded at estimated fair value. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders’ equity. Realized gains and losses are included in other income, in the unaudited condensed statements of operations. The Company evaluates its investments to determine whether those with unrealized loss positions are other than temporarily impaired. Impairments are considered to be other than temporary if they are related to deterioration in credit risk or if it is likely that the Company will sell the securities before recovery of their cost basis.

 

Inventory

 

The majority of the Company’s products are manufactured by third parties that retain ownership of the inventory until title is transferred to the customer at the shipping point. In certain instances shipping terms are delivery at place and the Company is responsible for arranging transportation and delivery of goods ready for unloading at the named place. In those instances the Company bears all risk involved in bringing the goods to the named place and records the related inventory in transit to the customer as inventory on the accompanying balance sheet. The Company also manufactures certain of its products at its facility located in Scottsdale, Arizona.

 

Inventory is stated at the lower of cost or net realizable value. For items manufactured by the Company, cost is determined using the weighted average cost method. For items manufactured by third parties, cost is determined using the first-in, first-out (FIFO) method. Any adjustments to reduce the cost of inventories to their net realizable value are recognized in earnings in the current period. As of September 30, 2020, the Company’s inventories consist primarily of raw materials. Provisions for excess and obsolete inventories are estimated based on product life cycles, quality issues, and historical experience. As of September 30, 2020, and December 31, 2019, there is no provision for excess and obsolete inventories.

 

Note 2. Summary of Significant Accounting Policies

 

During the three and nine months ended September 30, 2020, there have been no material changes to the Company’s significant accounting policies as described in the Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

Recent Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842), which requires lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right-of-use assets. Because of the Company’s emerging growth status, ASU 2016-02 is effective for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021. The Company will adopt the new accounting standard using the modified retrospective transition option as of the effective date on January 1, 2021. The Company’s initial evaluation of its current leases does not indicate that the adoption of this standard will have an impact on its statements of operations. The Company expects that the adoption of the standard will have an impact on its balance sheets for the recognition of certain operating leases as right-of-use assets and lease liabilities.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. This standard changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In December 2019, the FASB issued ASU 2019-10, Effective Dates which updated the effective dates of adoption of ASU 2016-13. ASU 2016-13 is effective, for Smaller Reporting Companies, for annual and interim periods in fiscal years beginning after December 15, 2022. Companies are required to adopt the standard using a modified retrospective adoption method. The Company continues to evaluate the impact of the standard on its financial statements.

9


Airgain, Inc.

Notes to Condensed Financial Statements

(Unaudited)

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment, which simplifies the test for goodwill impairment by removing Step 2 which requires a hypothetical purchase price allocation and may require the services of valuation experts. An entity will, therefore, perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the fair value, not to exceed the total amount of goodwill allocated to the reporting unit. An entity still has the option to perform a qualitative assessment to determine if the quantitative impairment test is necessary. ASU 2017-04 will be effective for the Company in annual periods beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company intends to early adopt ASU 2017-04 and believes the standard will have no impact on its ongoing financial reporting.

In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326), Targeted Transition Relief, which provides entities that have certain instruments within the scope of Accounting Standards Codification (ASC) 326-20, Financial Instruments-Credit Losses-Measured at Amortized Cost, with an option to irrevocably elect the fair value option for eligible instruments. The effective date and transition methodology for this standard are the same as in ASU 2016-13. The Company continues to evaluate the impact of the standard on its financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in accounting standards. The amendments in the ASU include removing exceptions to incremental intraperiod tax allocation of losses and gains from different financial statement components, exceptions to the method of recognizing income taxes on interim period losses, and exceptions to deferred tax liability recognition related to foreign subsidiary investments. In addition, the ASU requires that entities recognize franchise tax based on an incremental method and requires an entity to evaluate the accounting for step-ups in the tax basis of goodwill as inside or outside of a business combination. Based on the Company’s emerging growth company status the amendments in the ASU are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. We have not early adopted this ASU as of September 30, 2020. The ASU is currently not expected to have a material impact on the Company’s financial statements.

 

Note 3. Net Income (Loss) Per Share

Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average shares of common stock outstanding for the period. Diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted average shares of common stock outstanding for the period plus amounts representing the dilutive effect of securities that are convertible into common stock. The Company calculates diluted income (loss) per common share using the treasury stock method.

The following table presents the computation of net income (loss) per share (in thousands except per share data):

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(261

)

 

$

(135

)

 

$

(2,199

)

 

$

863

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

9,710

 

 

 

9,711

 

 

 

9,694

 

 

 

9,678

 

Plus dilutive effect of potential common shares

 

 

 

 

 

 

 

 

 

 

 

405

 

Weighted average common shares outstanding - diluted

 

 

9,710

 

 

 

9,711

 

 

 

9,694

 

 

 

10,083

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.03

)

 

$

(0.01

)

 

$

(0.23

)

 

$

0.09

 

Diluted

 

$

(0.03

)

 

$

(0.01

)

 

$

(0.23

)

 

$

0.09

 

 

10


Airgain, Inc.

Notes to Condensed Financial Statements

(Unaudited)

 

Diluted weighted average common shares outstanding for the nine months ended September 30, 2019 includes 3,000 warrants and 402,000 options.

 

Potentially dilutive securities (in common stock equivalent shares) not included in the calculation of diluted net income (loss) per share because to do so would be anti-dilutive are as follows (in thousands):

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Stock options and restricted stock

 

 

1,451

 

 

 

721

 

 

 

1,622

 

 

 

457

 

Warrants outstanding

 

 

3

 

 

 

51

 

 

 

51

 

 

 

 

Total

 

 

1,454

 

 

 

772

 

 

 

1,673

 

 

 

457

 

 

Note 4. Cash, Cash Equivalents and Short-Term Investments

The following tables show the Company’s cash and cash equivalents and short-term investments by significant investment category as of September 30, 2020, and December 31, 2019 (in thousands):

 

 

September 30, 2020

 

 

 

Amortized cost

 

 

Gross unrealized gains

 

 

Gross unrealized losses

 

 

Estimated fair value

 

 

Cash and cash equivalents

 

 

Short-term investments

 

Cash

 

$

2,577

 

 

$

 

 

$

 

 

$

2,577

 

 

$

2,577

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds